Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.

There are currently, however, two radioligands that are United States Food and Drug Administration (FDA)-approved for the treatment of mCRPC patients: Patients with advanced prostate cancer are at ...

Professor Adrian Crellin, 70, noticed blood in his urine and promptly sought medical attention from his GP, leading to a ...

More men are getting checked for prostate cancer and realising they have the disease at an early stage, but charity Prostate Cancer UK warns many will be symptomless ...

A top UK doctor has been left ‘devastated’ after being diagnosed with an incurable cancer he’s spent his life treating.

Since the initial diagnosis, Prof Crellin has undergone chemotherapy and radiotherapy and continues to receive hormone ...

Two metastatic lesions in the middle section ... that are used to diagnose prostate cancer. Source: Prostate Cancer UK A follow-up bone scan identified a tumour in the man's right shinbone ...

Further tests, such as CT scans and bone scans, may be performed to determine whether prostate cancer has spread. Management strategies for prostate cancer should be guided the severity of the ...

Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including ...